Philip A. Starr

Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease

Kenneth A. Follett, Frances M. Weaver, Matthew Stern et al. · New England Journal of Medicine · 2010 · 1.3K citations · Full text

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

William J. Marks, Raymond T. Bartus, João Siffert et al. · The Lancet Neurology · 2010 · 669 citations

Neurodegenerative Diseases, Neurology, Gene Delivery +4

Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease

Coralie de Hemptinne, Nicole C. Swann, Jill L. Ostrem et al. · Nature Neuroscience · 2015 · 624 citations · Full text

Stimulation Device, Neurophysiology, Medicine +11

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

William J. Marks, Jill L. Ostrem, L. Verhagen et al. · The Lancet Neurology · 2008 · 581 citations

Neurodegenerative Diseases, Idiopathic Parkinson, Medicine +4

Exaggerated phase–amplitude coupling in the primary motor cortex in Parkinson disease

Coralie de Hemptinne, Elena Ryapolova-Webb, Ellen L. Air et al. · Proceedings of the National Academy of Sciences · 2013 · 562 citations · Full text